371 related articles for article (PubMed ID: 29764981)
1. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.
Fratta P; Sivakumar P; Humphrey J; Lo K; Ricketts T; Oliveira H; Brito-Armas JM; Kalmar B; Ule A; Yu Y; Birsa N; Bodo C; Collins T; Conicella AE; Mejia Maza A; Marrero-Gagliardi A; Stewart M; Mianne J; Corrochano S; Emmett W; Codner G; Groves M; Fukumura R; Gondo Y; Lythgoe M; Pauws E; Peskett E; Stanier P; Teboul L; Hallegger M; Calvo A; Chiò A; Isaacs AM; Fawzi NL; Wang E; Housman DE; Baralle F; Greensmith L; Buratti E; Plagnol V; Fisher EM; Acevedo-Arozena A
EMBO J; 2018 Jun; 37(11):. PubMed ID: 29764981
[TBL] [Abstract][Full Text] [Related]
2. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
[TBL] [Abstract][Full Text] [Related]
3. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
[TBL] [Abstract][Full Text] [Related]
4. Splicing repression is a major function of TDP-43 in motor neurons.
Donde A; Sun M; Ling JP; Braunstein KE; Pang B; Wen X; Cheng X; Chen L; Wong PC
Acta Neuropathol; 2019 Nov; 138(5):813-826. PubMed ID: 31332509
[TBL] [Abstract][Full Text] [Related]
5. ALS-linked TDP-43
Watanabe S; Oiwa K; Murata Y; Komine O; Sobue A; Endo F; Takahashi E; Yamanaka K
Mol Brain; 2020 Jan; 13(1):8. PubMed ID: 31959210
[TBL] [Abstract][Full Text] [Related]
6. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
Ebstein SY; Yagudayeva I; Shneider NA
Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
[TBL] [Abstract][Full Text] [Related]
7. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
[TBL] [Abstract][Full Text] [Related]
8. Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation.
Sugai A; Kato T; Koyama A; Koike Y; Konno T; Ishihara T; Onodera O
Neurobiol Dis; 2019 Oct; 130():104534. PubMed ID: 31310801
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of cryptic splicing associated with TDP-43 depletion.
Humphrey J; Emmett W; Fratta P; Isaacs AM; Plagnol V
BMC Med Genomics; 2017 May; 10(1):38. PubMed ID: 28549443
[TBL] [Abstract][Full Text] [Related]
11. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
[TBL] [Abstract][Full Text] [Related]
12. A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue.
Cao MC; Ryan B; Wu J; Curtis MA; Faull RLM; Dragunow M; Scotter EL
Neurobiol Dis; 2023 Sep; 185():106245. PubMed ID: 37527763
[TBL] [Abstract][Full Text] [Related]
13. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
[TBL] [Abstract][Full Text] [Related]
14. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43.
Arnold ES; Ling SC; Huelga SC; Lagier-Tourenne C; Polymenidou M; Ditsworth D; Kordasiewicz HB; McAlonis-Downes M; Platoshyn O; Parone PA; Da Cruz S; Clutario KM; Swing D; Tessarollo L; Marsala M; Shaw CE; Yeo GW; Cleveland DW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):E736-45. PubMed ID: 23382207
[TBL] [Abstract][Full Text] [Related]
15. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS.
Shiga A; Ishihara T; Miyashita A; Kuwabara M; Kato T; Watanabe N; Yamahira A; Kondo C; Yokoseki A; Takahashi M; Kuwano R; Kakita A; Nishizawa M; Takahashi H; Onodera O
PLoS One; 2012; 7(8):e43120. PubMed ID: 22900096
[TBL] [Abstract][Full Text] [Related]
16. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models.
Tan Q; Yalamanchili HK; Park J; De Maio A; Lu HC; Wan YW; White JJ; Bondar VV; Sayegh LS; Liu X; Gao Y; Sillitoe RV; Orr HT; Liu Z; Zoghbi HY
Hum Mol Genet; 2016 Dec; 25(23):5083-5093. PubMed ID: 28007900
[TBL] [Abstract][Full Text] [Related]
17. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
18. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
[TBL] [Abstract][Full Text] [Related]
19. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.
White MA; Kim E; Duffy A; Adalbert R; Phillips BU; Peters OM; Stephenson J; Yang S; Massenzio F; Lin Z; Andrews S; Segonds-Pichon A; Metterville J; Saksida LM; Mead R; Ribchester RR; Barhomi Y; Serre T; Coleman MP; Fallon JR; Bussey TJ; Brown RH; Sreedharan J
Nat Neurosci; 2018 Apr; 21(4):552-563. PubMed ID: 29556029
[TBL] [Abstract][Full Text] [Related]
20. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.
Williamson MG; Finelli MJ; Sleigh JN; Reddington A; Gordon D; Talbot K; Davies KE; Oliver PL
Hum Mol Genet; 2019 Nov; 28(21):3584-3599. PubMed ID: 31642482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
